Keyphrases
Tumor mutation Burden
100%
Mismatch Repair
100%
Rhabdoid Tumor
100%
DNA Mismatch Repair
100%
Checkpoint Immunotherapy
100%
Programmed Death-ligand 1 (PD-L1)
83%
Tumor mutational Burden
66%
Tumor
50%
Germ Cells
33%
Immunohistochemistry
33%
Whole Exome Sequencing
33%
Primary Tumor
33%
SMARCB1
33%
PD-L1 Tumor Proportion Score
33%
INI1
33%
CD-8
16%
Tumor Cells
16%
Malignancy
16%
Cell Tumor
16%
Patient Demographics
16%
Immune Checkpoint Inhibitors
16%
Metastatic Tumor
16%
POLE mutation
16%
Pediatric Tumors
16%
Membrane Expression
16%
Tumor-infiltrating Lymphocytes
16%
Driver mutations
16%
Nuclear Expression
16%
Checkpoint Therapy
16%
DNA Mismatch Repair Protein
16%
Tumor Proportion Score
16%
Relapsed Tumor
16%
Medicine and Dentistry
Neoplasm
100%
Immunotherapy
100%
DNA Mismatch Repair
100%
Malignant Rhabdoid Tumour
100%
Tumor Mutation Burden
100%
Programmed Death-Ligand 1
45%
Immunohistochemistry
18%
Exome Sequencing
18%
Germ Cell
18%
Biological Marker
9%
CD8 Antigen
9%
Cancer
9%
Metastatic Carcinoma
9%
Tumor Cell
9%
Primary Tumor
9%
Somatics
9%
Patient Population
9%
Immune Checkpoint Inhibitor
9%
Pediatric Cancer
9%
Tumor Infiltrating Lymphocyte
9%
Mismatch Repair Protein
9%
Immunology and Microbiology
Immunotherapy
100%
Programmed Death-Ligand 1
100%
Mismatch DNA Repair
100%
Whole Exome Sequencing
40%
Mismatch Repair
40%
Germ Cell
40%
CD8
20%
Tumor Cell
20%
Tumor-Associated Macrophage
20%
Lineages
20%
Immunity
20%
Biochemistry, Genetics and Molecular Biology
DNA Mismatch Repair
100%
PD-L1
100%
Germline
40%
Germ Cell
40%
Exome Sequencing
40%
SMARCB1
40%
CD8
20%
Tumor-Associated Macrophage
20%
Immune Checkpoints
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Immunotherapy
100%
Rhabdoid Tumor
100%
Biological Marker
6%
Primary Tumor
6%
CD8 Antigen
6%
Metastasis
6%
Immune Checkpoint Inhibitor
6%
Mismatch Repair Protein
6%